Skip to content. | Skip to navigation

Personal tools

Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home / News

News

Jun 19, 2024 Games and paella party at the CIRI

CIRI members gathered for a party with outdoor games and a giant paella to share on Friday, June 14.

Read More…

May 22, 2024 Endogenous retroviruses make a stop in Zaragoza

Last year more than 40 researchers gathered in Rome for the first HERVCOV project annual meeting. This year it's time to visit another of the project partners' cities and the 2nd Annual Meeting will be held in Zaragoza, headquarters of the Instituto Aragonés de Ciencias de la Salud (IACS) and IIS Aragón.

Read More…

May 21, 2024 The CIRI at Pint of Science 2024

Every year, the Pint of Science festival brings together scientists and the curious for 3 evenings of popularizing science in bars. Here's a look back at CIRI doctoral students' participation in the 2024 edition!

Read More…

May 13, 2024 Autophagy, a key role in the pathophysiology of Crohn's disease

In a new study published in the journal Autophagy, CIRI researchers have shown for the first time that, in patients with Crohn's disease, the expression of autophagic gene variants strongly affects autophagic dynamics, known as autophagic flux.

Read More…

May 03, 2024 Impact of vaccination on induction of mucosal immunity with mRNA vaccines against Covid-19 epidemic.

Teams from the Immunology Department of the Pitié-Salpêtrière AP-HP hospital, Inserm and Sorbonne University, coordinated by Prof. Guy Gorochov, have conducted a study on the ability of Covid-19 mRNA vaccines to induce a mucosal immune response. CIRI members took part in this study. The results were published in JAMA Network Open on April 23, 2024.

Read More…

Apr 30, 2024 Recent books published by members of the CIRI

Members of the CIRI contributed to two books that were recently published. One is about the history of microbiology, and the other tackles research progress linked to the COVID-19 pandemic.

Read More…

Apr 23, 2024 David Durantel is the new President Elect of the International Society for Antiviral Research

David Durantel (HepVir team and virology specialty coordinator) was elected President Elect of the ISAR (International Society for Antiviral Research), thus strenghtening the role of CIRI researchers in the international area of virology and antiviral research!

Read More…

Apr 23, 2024 The LIA RESPIVIR was honored during the meeting of the French and Quebec Prime Ministers

The RESPIVIR France - Canada International Research Laboratory was very well received at the 21st alternating meeting between the Quebec and French prime ministers, François Legault and Gabriel Attal, which took place in Quebec from April 10 to 12.

Read More…

Mar 11, 2024 Kick-off of the industrial chair VIRESP

On Wednesday January 24, 2024, Université Claude Bernard Lyon 1 (UCBL), Hospices Civils de Lyon (HCL) (HCL), the French National Research Agency (ANR) and Sanofi officially launched the the VIRESP industrial chair, a research project focusing on the development of techniques and tools for analyzing the risk of infection and the morbidity rate of diseases in different populations, but also to determine the benefits of vaccination programs.

Read More…

Mar 19, 2024 from 06:00 PM to 08:00 PM 2 CIRI PhD students are local finalists of MT180

On March 19, the local finale of Ma Thèse en 180 secondes will take place, with the 12 finalists. Among them, two are doing their PhD at the CIRI: Xanthe Adams-Ward (LegioPath) et Iris Dadole (Persist).

Grand Amphithéâtre de l'Université de Lyon - 90 rue Pasteur 69007 Lyon - et en direct sur Youtube

Read More…

Feb 29, 2024 Rare Disease Day 2024

February 29, 2024 is Rare Disease Day. This is an opportunity to thank the clinicians and researchers who are advancing research on this subject at CIRI, as well as our patients!

Read More…

Feb 04, 2024 from 10:00 AM to 10:45 AM "Têtes chercheuses": research in cancerology, presented by the fondation ARC

The ARC Foundation brings together 5 leading cancer researchers for a 45-minute program. It will give the floor to experienced researchers and young talents, all ready to take up, together, the challenges of curing more patients.

Read More…

Jan 31, 2024 VirPath team wins two awards of research and innovation

The VirPath team was awarded two times during the 2023 research and innovation awards ceremony of the Université Claude Bernard Lyon 1. We look back at these awards and on the research program of the International Associate Laboratory RESPIVIR France-Canada.

Read More…

from Feb 03, 2024 12:00 AM to Feb 04, 2024 12:00 AM Demain, mais en mieux !

Meet with Cyrille Mathieu at the Yggdrasil festival, to learn all about viruses!

Eurexpo Lyon

Read More…

Jan 29, 2024 Voeux 2024

Le CIRI vous présente ses meilleurs voeux pour l'année 2024.

Read More…

Dec 01, 2023 COVID-19: Multisystem Inflammatory Syndrome in Children existed before the pandemic

During the COVID-19 pandemic, multisystemic inflammatory syndrome affected 1,100 children. Since this first description in 2020, CIRI researchers, HCL clinicians and other international collaborators have discovered that this syndrome existed before COVID-19, and that other infectious agents could lead to this severe inflammatory syndrome in children. These findings are published in the New England Journal of Medicine.

Read More…

Nov 27, 2023 2023 PEPR MIE recipients : CIRI involved in 6 projects

Among the 11 laureates of the PEPR MIE 2023 call for projects (ANRS|Emerging Infectious Diseases), 6 projects involve CIRI teams. Their common aim is to better understand, prevent and control the emergence or re-emergence of infectious diseases.

Read More…

Nov 24, 2023 CERP/PHE3ID team awarded the Shapemed@Lyon call "Projets d'amorçage"

The PHE3ID/CERP research team has been awarded with one of the first Projets d’Amorçage supported by SHAPE-Med@Lyon

Read More…

Nov 14, 2023 Launch of the Chaire industrielle REVIDA

On october 11, the Chaire industrielle REVIDA about respiratory infectious diseases, led by the researcher Sophie Trouillet-Assant (UCBL/HCL), was officially launched by the Université Claude Bernard Lyon 1, the Hospices Civils de Lyon, and bioMérieux, with the support of the Agence nationale de la recherche. It should enable the improvement of the capacity of health systems to face the emerging of new respiratory diseases.

Read More…

Oct 19, 2023 Sidaction donors discover CIRI with the LP2L team

On October 12, 2023, Sidaction donors visited the laboratory of the LP2L team (A. Cimarelli, L. Etienne). Here's a look back at this successful moment of sharing.

Read More…

May 23, 2023 Le CIRI au 23ème ANRS | EID AC42

Le CIRI est représenté, ces mardi 23 et mercredi 24 mai 2023, au meeting du Réseau National des Hépatites virales qui se déroule à Paris.

Read More…

Apr 04, 2023 10:10 PM New publication COVID Nature communication

New publication - VIV Team in Nature communication

Read More…

Mar 24, 2023 Covid-19: infection-vaccination combination best protects against reinfection with SARS-CoV-2

Several CIRI teams carried out this work, published in the journal Science Translational Medicine.

Read More…

Jun 28, 2022 HERVCOV: A european project coordinated by Branka Horvat

The protein that opens doors to the medicine of the future and treatment of COVID-19

Read More…

from May 31, 2022 01:45 PM to Jun 20, 2022 01:45 PM SFM Mycodays Lyon 20 – 22 juin

Read More…

Feb 08, 2022 Antibiotic resistance: How some bacteria acquire resistance genes from their environment?

Antibiotic resistance has made certain infections, sometimes common, such as urinary and respiratory infections, impossible to treat, representing a major setback in the medical care of human and animal patients. This resistance has thus become a major health issue, which has led the WHO (World Health Organization) to establish a list of bacteria in which antibiotic resistance is particularly worrying.In a new study published in the journal mBio, we focused on one of these bacteria that are particularly resistant to antibiotics, Acinetobacter baumannii. The latter is responsible for many opportunistic and nosocomial infections. We have determined the mechanisms that allow this bacterium to rapidly acquire resistance genes from neighboring bacteria.

Read More…

from Mar 15, 2022 09:00 AM to Mar 16, 2022 06:00 PM Journées scientifiques de l'ANRS

Maladies infectieuses émergentes

Read More…